Spark Therapeutics completes regulatory filing application for its experimental gene therapy medicine – Philly.com
Philly.com |
Spark Therapeutics completes regulatory filing application for its experimental gene therapy medicine
Philly.com The gene therapy has received orphan, or rare-drug, designation in the United States and Europe. Companies that pursue a cure or treatment for a specific condition that affects a small percentage of the population — fewer than 200,000 in the United … |
